Episode Details

Back to Episodes
Episode 174: Biotech's trust issues, overwhelmed health workers, & the nuances of insider trading

Episode 174: Biotech's trust issues, overwhelmed health workers, & the nuances of insider trading

Published 5 years, 2 months ago
Description
First, we discuss a sudden spike of FDA rejections, which has resurfaced a time-honored frustration: You can’t always trust biotech companies to be honest about their conversations with the agency. Then, STAT's Lev Facher joins us to share his reporting from Louisiana, where a surge of Covid-19 deaths among the unvaccinated is having devastating effects on health workers. Before that, we talk about a curious case of alleged insider trading, medical conferences in the time of Delta, and the global vaccine push.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us